Home
>
National Drug Code (NDC)
>
Halaven
Halaven - 62856-389-01 - (eribulin mesylate)
Drug Information of Halaven
| Product NDC: | 62856-389 |
| Proprietary Name: | Halaven |
| Non Proprietary Name: | eribulin mesylate |
| Active Ingredient(s): | .5 mg/mL & nbsp; eribulin mesylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Halaven
| Product NDC: | 62856-389 |
| Labeler Name: | Eisai, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA201532 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101115 |
Package Information of Halaven
| Package NDC: | 62856-389-01 |
| Package Description: | 1 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL |
NDC Information of Halaven
| NDC Code | 62856-389-01 |
| Proprietary Name | Halaven |
| Package Description | 1 VIAL in 1 CARTON (62856-389-01) > 2 mL in 1 VIAL |
| Product NDC | 62856-389 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | eribulin mesylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101115 |
| Marketing Category Name | NDA |
| Labeler Name | Eisai, Inc |
| Substance Name | ERIBULIN MESYLATE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
